Main content
Sorry, this episode is not currently available

Covid vaccine: Single dose vaccine 66% effective

Belgian company Janssen says its Covid-19 vaccine is 66% effective

We bring you today’s developments and answer audience questions on Covid-19 vaccines, after encouraging results from the trials of two new vaccines. The Belgian pharmaceutical company Janssen, owned by Johnson & Johnson, has announced that a single dose of its vaccine prevents 66% of Covid cases. Also, a new Novavax vaccine has been shown to be 89.3% effective in large-scale trials in the UK. And the EU's drugs regulator has approved the use of the AstraZeneca Covid vaccine for people aged over 18.

We also speak to parents about the challenges of parenting and home schooling during lockdown.

And we hear from people in Lebanon who have been protesting against a strict coronavirus lockdown.

(Photo: Screengrab taken from undated video issued by Johnson and Johnson showing vials of the Janssen COVID-19 vaccine. Credit: Janssen Pharmaceutical Companies/PA Wire)

53 minutes

Broadcast

  • Fri 29 Jan 2021 16:06GMT

Sexual Harassment

People's experiences of inappropriate behaviour

Trump's Towns

Perspectives from and reaction to President Trump's core supporters

Refugee Stories

The experiences of refugees building new lives

At the heart of the story

Bringing you the latest on the news stories that matter

Telling my story

Stories, memories and experiences that changed lives